Abstract
Obesity has been a main risk for the development of diabetes mellitus, cardiovascular diseases and many other chronic problems worldwide. Lifestyle modification is the best way to lose weight but very hard to implement, thus pharmacotherapy is regarded as a good add-on to dietary and lifestyle therapies. This review provides an overview of the olistat, a drug for obesity approved by FDA, about its mechanism of action, efficacy for obesity and some other diseases including cardiovascular disease, type 2 diabetes and some cancers, as well as its safety and adverse effects.
Cite
CITATION STYLE
Qi, X. (2018). Review of the Clinical Effect of Orlistat. In IOP Conference Series: Materials Science and Engineering (Vol. 301). Institute of Physics Publishing. https://doi.org/10.1088/1757-899X/301/1/012063
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.